Exosomal CD40, CD25, and Serum CA19-9 as Combinatory Novel Liquid Biopsy Biomarker for the Diagnosis and Prognosis of Patients with Pancreatic Ductal Adenocarcinoma.
Saved in:
| Title: | Exosomal CD40, CD25, and Serum CA19-9 as Combinatory Novel Liquid Biopsy Biomarker for the Diagnosis and Prognosis of Patients with Pancreatic Ductal Adenocarcinoma. |
|---|---|
| Authors: | David P; Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany., Kouhestani D; Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany., Hansen FJ; Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany., Paul S; Department of Dermatology, University Hospital Erlangen, 91054 Erlangen, Germany., Czubayko F; Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany., Karabiber A; Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany., Weisel N; Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany., Klösch B; Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany., Merkel S; Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany., Ole-Baur J; Department of Dermatology, University Hospital Erlangen, 91054 Erlangen, Germany.; Medizinische Klinik IV (Hämatologie und Onkologie), Klinikum Bayreuth GmbH, 95445 Bayreuth, Germany., Gießl A; Department of Ophthalmology, University Hospital Erlangen, 91054 Erlangen, Germany., Van Deun J; Department of Dermatology, University Hospital Erlangen, 91054 Erlangen, Germany., Vera J; Department of Dermatology, University Hospital Erlangen, 91054 Erlangen, Germany., Mittelstädt A; Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany., Weber GF; Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.; Deutsches Zentrum für Immuntherapie, Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, 91054 Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), 91052 Erlangen, Germany. |
| Source: | International journal of molecular sciences [Int J Mol Sci] 2025 Feb 11; Vol. 26 (4). Date of Electronic Publication: 2025 Feb 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40003965 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Exosomal CD40, CD25, and Serum CA19-9 as Combinatory Novel Liquid Biopsy Biomarker for the Diagnosis and Prognosis of Patients with Pancreatic Ductal Adenocarcinoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22David+P%22">David P</searchLink>; Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Kouhestani+D%22">Kouhestani D</searchLink>; Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Hansen+FJ%22">Hansen FJ</searchLink>; Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Paul+S%22">Paul S</searchLink>; Department of Dermatology, University Hospital Erlangen, 91054 Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Czubayko+F%22">Czubayko F</searchLink>; Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Karabiber+A%22">Karabiber A</searchLink>; Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Weisel+N%22">Weisel N</searchLink>; Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Klösch+B%22">Klösch B</searchLink>; Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Merkel+S%22">Merkel S</searchLink>; Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Ole-Baur+J%22">Ole-Baur J</searchLink>; Department of Dermatology, University Hospital Erlangen, 91054 Erlangen, Germany.; Medizinische Klinik IV (Hämatologie und Onkologie), Klinikum Bayreuth GmbH, 95445 Bayreuth, Germany.<br /><searchLink fieldCode="AU" term="%22Gießl+A%22">Gießl A</searchLink>; Department of Ophthalmology, University Hospital Erlangen, 91054 Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Van+Deun+J%22">Van Deun J</searchLink>; Department of Dermatology, University Hospital Erlangen, 91054 Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Vera+J%22">Vera J</searchLink>; Department of Dermatology, University Hospital Erlangen, 91054 Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Mittelstädt+A%22">Mittelstädt A</searchLink>; Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Weber+GF%22">Weber GF</searchLink>; Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.; Deutsches Zentrum für Immuntherapie, Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, 91054 Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), 91052 Erlangen, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101092791%22">International journal of molecular sciences</searchLink> [Int J Mol Sci] 2025 Feb 11; Vol. 26 (4). <i>Date of Electronic Publication: </i>2025 Feb 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101092791 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1422-0067 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214220067%22">14220067 </searchLink><i>NLM ISO Abbreviation: </i>Int J Mol Sci <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40003965 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/ijms26041500 Languages: – Code: eng Text: English Titles: – TitleFull: Exosomal CD40, CD25, and Serum CA19-9 as Combinatory Novel Liquid Biopsy Biomarker for the Diagnosis and Prognosis of Patients with Pancreatic Ductal Adenocarcinoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: David P – PersonEntity: Name: NameFull: Kouhestani D – PersonEntity: Name: NameFull: Hansen FJ – PersonEntity: Name: NameFull: Paul S – PersonEntity: Name: NameFull: Czubayko F – PersonEntity: Name: NameFull: Karabiber A – PersonEntity: Name: NameFull: Weisel N – PersonEntity: Name: NameFull: Klösch B – PersonEntity: Name: NameFull: Merkel S – PersonEntity: Name: NameFull: Ole-Baur J – PersonEntity: Name: NameFull: Gießl A – PersonEntity: Name: NameFull: Van Deun J – PersonEntity: Name: NameFull: Vera J – PersonEntity: Name: NameFull: Mittelstädt A – PersonEntity: Name: NameFull: Weber GF IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 02 Text: 2025 Feb 11 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1422-0067 Numbering: – Type: volume Value: 26 – Type: issue Value: 4 Titles: – TitleFull: International journal of molecular sciences Type: main |
| ResultId | 1 |